Presentation is loading. Please wait.

Presentation is loading. Please wait.

The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled.

Similar presentations


Presentation on theme: "The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled."— Presentation transcript:

1 The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled study  Po Mui Lam, M.D., Wing Hung Tam, M.B.Ch.B., Ronald Ching Wan Ma, M.B.B.Chir., Lai Ping Cheung, M.Med., Michelle Hang Yuet Tsui, M.B.B.S., Peter Chun Yip Tong, Ph.D., Francis Chun Chung Chow, M.B.B.S., Christopher Wai Kei Lam, Ph.D., Michael Ho Ming Chan, M.B.Ch.B., Juliana Chung Ngor Chan, M.D., Christopher John Haines, M.D.  Fertility and Sterility  Volume 96, Issue 2, Pages e1 (August 2011) DOI: /j.fertnstert Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions

2 Figure 1 Flow diagram of the randomized controlled trial.
Fertility and Sterility  , e1DOI: ( /j.fertnstert ) Copyright © 2011 American Society for Reproductive Medicine Terms and Conditions


Download ppt "The reproductive and metabolic effect of rosiglitazone on Chinese women with polycystic ovarian syndrome—a double-blind randomized placebo-controlled."

Similar presentations


Ads by Google